Navigation Links
Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
Date:10/21/2008

e'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform includes the Isolagen Process(TM), a cell processing system for skin and tissue rejuvenation which is currently in clinical development for a broad range of aesthetic and therapeutic applications including wrinkles, acne scars, burns and periodontal disease. Isolagen also commercializes a scientifically-advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit http://www.isolagen.com.

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release, include, without limitation, the timely completion of the overall acne study, the timely completion of the Company's Phase III wrinkle study, and the Company's ability to raise additional funding, whether through strategic partners, financing, or otherwise. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of our control, that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Isolagen, Inc. Postpones Annual Meeting
2. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
3. Isolagen Modifies Ongoing Clinical Program for Acne Scars
4. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
5. Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
6. Isolagen, Inc. Receives Notification Letter from American Stock Exchange
7. Isolagen, Inc. Promotes Todd Greenspan to Chief Financial Officer (CFO)
8. Isolagen, Inc. Sells Switzerland Facility
9. Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex
10. Eligard(R) six-month formulation successfully completes European approval procedure
11. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 19, 2013 The Drug Delivery ... unprecedented access to the drug delivery partnering deals and ... , The report provides a detailed understanding and ... partnering deals. The majority of deals are discovery or ... an option right to license the license drug delivery ...
(Date:6/18/2013)... Alto, CA (PRWEB) June 18, 2013 Palo ... be one of America's greenest cities with its recent major ... Council authorized three major solar electric power purchase agreements ... to 182,500 megawatt-hours (MWh) of solar photovoltaic electric power per ... the City’s electric needs. That’s enough power to supply ...
(Date:6/18/2013)... research has shown that cancer cells have a much ... cells. Now, scientists at The University of Texas at ... a new strategy to combat lung cancer. , In ... PLOS ONE , UT Dallas researchers compared the ... lung cells taken from the same patient. , ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... June 18, 2013 A new $119 ... The burgeoning aquaculture industry is redefining the way consumers ... the most acclaimed personal culinary chefs on the Emerald ... benefits of sustainable seafood and the promising industry of ... these days. Many consumers strive to fully partake in ...
Breaking Medicine News(10 mins):Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... has a love-hate relationship with iron. Just the right amount is ... brain diseases like Alzheimer,s and Parkinson,s. Science knows ... women. These higher levels may be part of the explanation for ... But why do women have less iron in ...
... to perform everyday activities. This is not primarily due to ... was previously believed new research from the University of ... initiate and complete a task towards a specific goal. ... normally results in a degree of paralysis in the lower ...
... will discuss scientific studies of mutual interests and explore ... Oct. 24-26. The Ohio State University Medical Center is ... first of its kind between the two countries. , ... countries are expected to speak at the event that ...
... providers assess blood and tissue type as well as ... research indicates that checklist might also need to include ... shown the time of day transplant surgery is performed ... dysfunctional internal clocks is the first correlating circadian clocks ...
... 4 (HealthDay News) -- Readmission rates have increased in ... the country,s most elite academic medical centers, new research ... to the hospital within 30 days of being discharged ... as hospitals brace for penalties -- reduced payments for ...
... shows that exposure to stressors in the Neonatal Intensive ... brain structure and function of very preterm infants. According ... Neurology , a journal published by Wiley-Blackwell on behalf ... infants who experienced early exposure to stress displayed decreased ...
Cached Medicine News:Health News:Hysterectomy is associated with increased levels of iron in the brain 2Health News:Hysterectomy is associated with increased levels of iron in the brain 3Health News:Children with spina bifida need personal 'starter' 2Health News:Ohio State organizes research sharing between Brazil, US 2Health News:Circadian clock may impact organ transplant success 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 3Health News:Preterm infants exposed to stressors in NICU display reduced brain size 2
(Date:6/18/2013)... CITY , June 18, 2013 ... products for healthcare and life sciences research, today ... Services Administration (GSA) IT Schedule 70 supply contract ... certified to provide innovative IT solutions to government ... accordance with this contract, Remedy has placed its ...
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013 Valeant Pharmaceuticals International, ... today that it has filed a preliminary prospectus supplement to ... today made a similar filing with securities regulatory authorities in ... in connection with a public offering of its common shares ... The Company will also grant to the underwriters ...
Breaking Medicine Technology:Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
...  GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 2011 on Thursday, March 15, 2012, before the U.S. financial ... and conference call at 10:00 a.m. EDT to discuss the ... outlook. To listen to the live conference ...
... release of System 7 – the next generation of heavy ... such as hip and knee replacements. System 7 offers the ... and highest performing power tool system ever from Stryker. ... heavy duty power tools in 1982, and has built a ...
Cached Medicine Technology:GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 2Stryker Launches Next Generation Heavy Duty Surgical Power Tools 2
Inquire...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
20L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: